Stomach Cancer Clinical Trials

A listing of Stomach Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Tucson Arizona 85715

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

California

UPDATED

La Jolla California 92037-0845

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90025

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

View More ▼

UPDATED

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90033

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Los Angeles California 90033

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Santa Monica California 90404

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Whittier California

A clinical research study for the treatment of Gastric Adenocarcinoma

Duarte California 91010-0269

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Stanford California 94305

A clinical trial seeking patients for a research study for the treatment of Stomach Cancer, Gastric (Stomach) Cancer, Neoplasm of Cardioesophageal Junction or Gastrointestinal Stromal Tumor (GIST)

Connecticut

UPDATED

Plainville Connecticut

A clinical research study for the treatment of Gastric Adenocarcinoma

Florida

UPDATED

Debary Florida

A clinical research study for the treatment of Gastric Adenocarcinoma

Illinois

UPDATED

Harvey Illinois

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Naperville Illinois

A clinical research study for the treatment of Gastric Adenocarcinoma

Indiana

UPDATED

Goshen Indiana

A clinical research study for the treatment of Gastric Adenocarcinoma

Kansas

Westwood Kansas 66205

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Louisiana

UPDATED

New Orleans Louisiana

A clinical research study for the treatment of Gastric Adenocarcinoma

Maine

UPDATED

Scarborough Maine

A clinical research study for the treatment of Gastric Adenocarcinoma

Massachusetts

Worcester Massachusetts 01655

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

New Jersey

UPDATED

Morristown New Jersey

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Sparta New Jersey

A clinical research study for the treatment of Gastric Adenocarcinoma

New York

UPDATED

New York New York

A clinical research study for the treatment of Gastric Adenocarcinoma

Bronx New York 10461

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

New York New York 10021

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

North Carolina

UPDATED

Charlotte North Carolina 28204

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Durham North Carolina

A clinical research study for the treatment of Gastric Adenocarcinoma

Ohio

UPDATED

Cincinnati Ohio

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Columbus Ohio

A clinical research study for the treatment of Gastric Adenocarcinoma

Oklahoma

UPDATED

Tulsa Oklahoma 74146

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

South Carolina

UPDATED

Charleston South Carolina

A clinical research study for the treatment of Gastric Adenocarcinoma

South Dakota

UPDATED

Watertown South Dakota

A clinical research study for the treatment of Gastric Adenocarcinoma

Tennessee

UPDATED

Chattanooga Tennessee

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Knoxville Tennessee

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Nashville Tennessee

A clinical research study for the treatment of Gastric Adenocarcinoma

Texas

UPDATED

Fort Worth Texas

A clinical research study for the treatment of Gastric Adenocarcinoma

UPDATED

Houston Texas 77030

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Houston Texas 77030

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Temple Texas

A clinical research study for the treatment of Gastric Adenocarcinoma

View More ▼

Temple Texas 76508

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Washington

MultiCare Health System
Tacoma Washington 98405

Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab Drug Product(IMC-1121B) Versus mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction or Stomach

View More ▼

UPDATED

Seattle Washington 98109

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Seattle Washington 98109

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

UPDATED

Seattle Washington 98195

A Phase 1 clinical study for patients with Neoplasms, Advanced Solid Tumors

Olympia Washington 98502

A clinical trial to evaluate treatments using Ramucirumab (LY3009806) and Paclitaxel for patients with Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma, Gastric Cancer

Argentina

UPDATED

Buenos Aires 1025

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma

UPDATED

Rosario 2000

Patients are needed to participate in a clinical research study evaluating Ramucirumab (LY3009806) for the treatment of Gastric Adenocarcinoma or Gastroesophageal Junction (GEJ)Adenocarcinoma